This announcement is a separate document:
江苏世纪同仁律师事务所关于南京伟思医疗科技股份有限公司2022年限制性股票激励计划与2023年限制性股票激励计划调整、作废及归属相关事项的法律意见书
Legal Opinion of Jiangsu Century Same-Team Law Firm on Matters Related to the Modification, Cancellation and Attribution of the 2022 and 2023 Restricted Stock Incentive Plans of Nanjing Vishee Medical Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.